Page last updated: 2024-11-08

pluviatolide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pluviatolide: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(-)-pluviatolide : A butan-4-olide that is dihydrofuran-2(3H)-one which is substituted by a vanillyl group at position 3 and by a 3,4-methylenedioxybenzyl group at position 4 (the R,R stereoisomer). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID168759
CHEMBL ID63962
CHEBI ID90896
SCHEMBL ID18243823
MeSH IDM0066845

Synonyms (19)

Synonym
pluviatolide
(-)-pluviatolide
CHEMBL63962
(3r,4r)-4-(1,3-benzodioxol-5-ylmethyl)-3-(4-hydroxy-3-methoxybenzyl)dihydrofuran-2(3h)-one
28115-68-6
(3r,4r)-4-(1,3-benzodioxol-5-ylmethyl)-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one
2(3h)-furanone, 4-(1,3-benzodioxol-5-ylmethyl)dihydro-3-((4-hydroxy-3-methoxyphenyl)methyl)-, (3r-trans)-
CHEBI:90896
SCHEMBL18243823
((3r,4r)-4-(2h-1,3-benzodioxol-5-ylmethyl)-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one
(3r,4r)-4-(2h-1,3-benzodioxol-5-ylmethyl)-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one
C21191
Q27162877
(3r,4r)-4-(1,3-benzodioxol-5-ylmethyl)dihydro-3-[(4-hydroxy-3-methoxyphenyl)methyl]-2(3h)-furanone
4-[(2h-1,3-benzodioxol-5-yl)methyl]-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one
DTXSID00950854
CS-0213961
HY-N9926
AKOS040762210
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
benzodioxoles
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
lignanAny phenylpropanoid derived from phenylalanine via dimerization of substituted cinnamic alcohols, known as monolignols, to a dibenzylbutane skeleton. Note that while individual members of the class have names ending ...lignane, ...lignene, ...lignadiene, etc., the class names lignan, neolignan, etc., do not end with an "e".
butan-4-olideAny gamma-lactone having the lactone moiety derived from 4-hydroxybutanoic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
hinokinin biosynthesis08
yatein biosynthesis I010
hinokinin biosynthesis28
yatein biosynthesis I110

Bioassays (7)

Assay IDTitleYearJournalArticle
AID1226655Ratio of glucose uptake in rat L6 cells at 1.5 uM after 2 hrs to glucose uptake in rat L6 cells at 1.5 uM after 2 hrs in presence of 3 uM (-)-arctigenin2015ACS medicinal chemistry letters, Apr-09, Volume: 6, Issue:4
Design and synthesis of novel arctigenin analogues for the amelioration of metabolic disorders.
AID73178Cytotoxic effect against GLC4 (human small cell lung carcinoma cell line) using the microculture tetrazolium (MTT) assay based on continuous incubation1995Journal of medicinal chemistry, Jun-09, Volume: 38, Issue:12
Synthesis and cytotoxicity of novel lignans.
AID73177Cytotoxic effect against GLC4 (human small cell lung carcinoma cell line) using the microculture tetrazolium (MTT) assay based on 2 hr incubation1995Journal of medicinal chemistry, Jun-09, Volume: 38, Issue:12
Synthesis and cytotoxicity of novel lignans.
AID344455Antispasmodic activity in guinea pig ileum assessed as inhibition of acetylcholine-induced smooth muscle contraction2008Journal of natural products, Jul, Volume: 71, Issue:7
Chemical constituents of Aristolochia constricta: antispasmodic effects of its constituents in guinea-pig ileum and isolation of a diterpeno-lignan hybrid.
AID1226650Increase in glucose uptake in rat L6 cells at 1.5 uM pre-treated with compound for 30 mins using 2-deoxy-D-[1,2-3H]glucose and measured after 2 hrs in presence of 3 uM (-)-arctigenin by liquid scintillation counting method2015ACS medicinal chemistry letters, Apr-09, Volume: 6, Issue:4
Design and synthesis of novel arctigenin analogues for the amelioration of metabolic disorders.
AID1226645Increase in glucose uptake in rat L6 cells at 1.5 uM pre-treated with compound for 30 mins using 2-deoxy-D-[1,2-3H]glucose and measured after 2 hrs by liquid scintillation counting method2015ACS medicinal chemistry letters, Apr-09, Volume: 6, Issue:4
Design and synthesis of novel arctigenin analogues for the amelioration of metabolic disorders.
AID344454Antispasmodic activity in guinea pig ileum assessed as inhibition of electrically-induced smooth muscle contraction2008Journal of natural products, Jul, Volume: 71, Issue:7
Chemical constituents of Aristolochia constricta: antispasmodic effects of its constituents in guinea-pig ileum and isolation of a diterpeno-lignan hybrid.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.94 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]